pmc logo imageJournal ListSearchpmc logo image
Logo of vhriskmanJournal URL: redirect3.cgi?&&auth=0tYEgGDF1wOjodtll_KR2h0jf6CNfJc-VRC88qQqk&reftype=publisher&issue-id=163142&journal-id=391&FROM=TOC|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://dovepress.com/articles.php?journal_id=69
Other Issues:  previous | next | latest | archive
Volume 3(5);  October 2007
Reviews
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE®) in the management of hemophilia A
Amy D Shapiro
Vasc Health Risk Manag. 2007 October; 3(5): 555–565.
PMCID: PMC2291300
The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
Paolo Gelosa, Mauro Cimino, Alice Pignieri, Elena Tremoli, Uliano Guerrini, and Luigi Sironi
Vasc Health Risk Manag. 2007 October; 3(5): 567–577.
PMCID: PMC2291301
Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
John D Bisognano, Trent McLaughlin, Craig S Roberts, and Simon SK Tang
Vasc Health Risk Manag. 2007 October; 3(5): 579–585.
PMCID: PMC2291302
Comprehensive cardiovascular risk management – what does it mean in practice?
Leif Erhardt, Robert Moller, and Juan García Puig
Vasc Health Risk Manag. 2007 October; 3(5): 587–603.
PMCID: PMC2291303
Aldosterone antagonism in heart failure
Alan B Miller
Vasc Health Risk Manag. 2007 October; 3(5): 605–609.
PMCID: PMC2291304
Are pleiotropic effects of statins real?
Alberto Corsini, Nicola Ferri, and Michele Cortellaro
Vasc Health Risk Manag. 2007 October; 3(5): 611–613.
PMCID: PMC2291305
Cholesterol lowering for secondary prevention: What statin dose should we use?
Kiranbir Josan and Finlay A McAlister
Vasc Health Risk Manag. 2007 October; 3(5): 615–627.
PMCID: PMC2291306
Ischemic preconditioning: Protection against myocardial necrosis and apoptosis
Efstathios K Iliodromitis, Antigone Lazou, and Dimitrios Th Kremastinos
Vasc Health Risk Manag. 2007 October; 3(5): 629–637.
PMCID: PMC2291307
A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus
WH Wilson Tang
Vasc Health Risk Manag. 2007 October; 3(5): 639–645.
PMCID: PMC2291308
Nebivolol in the treatment of chronic heart failure
Angie Veverka and Jennifer L Salinas
Vasc Health Risk Manag. 2007 October; 3(5): 647–654.
PMCID: PMC2291309
Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia
Man-Chiu Poon
Vasc Health Risk Manag. 2007 October; 3(5): 655–664.
PMCID: PMC2291310
Optimizing combination treatment in the management of type 2 diabetes
Giuseppe Derosa and Salvadeo Sibilla
Vasc Health Risk Manag. 2007 October; 3(5): 665–671.
PMCID: PMC2291311
Cardiovascular disease and osteoporosis: Balancing risk management
Darren ER Warburton, Crystal Whitney Nicol, Stephanie N Gatto, and Shannon SD Bredin
Vasc Health Risk Manag. 2007 October; 3(5): 673–689.
PMCID: PMC2291312
Utilizing enoxaparin in the management of STEMI
Andrea Rubboli, Alessandro Capecchi, and Giuseppe Di Pasquale
Vasc Health Risk Manag. 2007 October; 3(5): 691–700.
PMCID: PMC2291313
Management of intracerebral hemorrhage
Ramandeep Sahni and Jesse Weinberger
Vasc Health Risk Manag. 2007 October; 3(5): 701–709.
PMCID: PMC2291314
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin
FD Richard Hobbs
Vasc Health Risk Manag. 2007 October; 3(5): 711–719.
PMCID: PMC2291315
A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes
Mozhgan Dorkhan and Anders Frid
Vasc Health Risk Manag. 2007 October; 3(5): 721–731.
PMCID: PMC2291316
Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors
Harold Bays and Peter H Jones
Vasc Health Risk Manag. 2007 October; 3(5): 733–742.
PMCID: PMC2291317
Macro- and micronutrients in patients with congestive heart failure, particularly African-Americans
Kevin P Newman, Syamal K Bhattacharya, Ahmad Munir, Richard C Davis, Judith E Soberman, and Kodangudi B Ramanathan
Vasc Health Risk Manag. 2007 October; 3(5): 743–747.
PMCID: PMC2291318
Original Research
Determinants of outcome in patients eligible for thrombolysis for ischemic stroke
Valeria Caso, Maurizio Paciaroni, Michele Venti, Francesco Palmerini, Giorgio Silvestrelli, Paolo Milia, Sergio Biagini, and Giancarlo Agnelli
Vasc Health Risk Manag. 2007 October; 3(5): 749–754.
PMCID: PMC2291319
Is general anesthesia a risk for myocardium? Effect of anesthesia on myocardial function as assessed by cardiac troponin-i in two different groups (isofluran+N2O inhalation and propofol+fentanyl iv anesthesia)
Demet Dogan Erol and Ibrahim Ozen
Vasc Health Risk Manag. 2007 October; 3(5): 755–758.
PMCID: PMC2291320
Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting
Brandon A Van Noord, Andrew H Lin, and Jeffery J Cavendish
Vasc Health Risk Manag. 2007 October; 3(5): 759–762.
PMCID: PMC2291321
Magnetic resonance imaging in coronary artery bypass surgery – improvement of global and segmental function in patients with severely compromized left ventricular function
Matthias Thielmann, Peter Hunold, Claudia Böhm, Parwis Massoudy, and Heinz Jakob
Vasc Health Risk Manag. 2007 October; 3(5): 763–768.
PMCID: PMC2291322
Case Reports
Emergency endovascular repair of acute descending thoracic aortic dissection
Muhammad Anees Sharif, Mark Edward O’Donnell, Paul Henry Blair, and Peter Kennedy
Vasc Health Risk Manag. 2007 October; 3(5): 769–773.
PMCID: PMC2291323
Acute coronary syndrome associated with Churg-Strauss syndrome
Annette Doris Wagner, Gerd Peter Meyer, Markus Rihl, Anke Rathmann, Ulrike Wittkop, Henning Zeidler, Hermann Haller, and Joachim Lotz
Vasc Health Risk Manag. 2007 October; 3(5): 775–779.
PMCID: PMC2291324
ISVH Society News
ISVH Society September Newsletter
W.C. Roberts, A. Zanchetti, R. Asmar, J. Cameron, A. Achimastos, E. Agabiti-Rosei, J. Cockcroft, D. Duprez, J. Filipovsky, J. Izzo, A. Nicolaides, R. Sa Cunha, H. Struijker-Boudier, K. Takazawa, L. Van Bortel, H. Wang, A. Benetos, C. Calvo, J.N. Cohn, K. Cruickshank, P. de Leeuw, N. de Luca, N. Feely, S. Franklin, D. Kass, B. Kingwell, K.K. Koh, S. Laurent, G. Mitchell, J. Palma-Gamiz, B. Pannier, C.G. Park, J. Polonia, C. Rajkumar, E. Schiffrin, A. Scuteri, Y. Sirenko, J. Topouchian, J. Toto-Moukouo, W. Van Meighem, and B. Waeber
Vasc Health Risk Manag. 2007 October; 3(5): 781.
PMCID: PMC2291448
| Full Text |
Other Issues:  previous | next | latest | archive